LAPTM4B and neoplasm: We acquired diverse tumor data from TCGA and identified LAPTM4B up-regulation in 12 of 33 tumor types, including Liver Hepatocellular Carcinoma (LIHC) (p < 0.0001) (Fig. 1A).